Strategic Signals Weekly
Licensing deals, strategic reviews, and financing events from regulatory filings. Part of the RxDataLab platform: clinical trials, SEC filings, and hedge fund positioning, linked by company.
Weekly Signal Volume
Licensing & Partnerships
New collaboration agreements, licensing deals, and partnership announcements.
| Filed | Company |
|---|---|
| Feb 4 | Entera Bio Ltd. (ENTX) ...Agreement Amended and Restated Collaboration and License Agreement As previously reported, on March 16, 2025, Entera Bio Ltd., a company organized under the laws of the State of Israel (the " Company "), entered into a collaboration and license agreement (the "...
[SEC] |
Financing Events
Capital raises, ATM programs, debt offerings, and other financing activities.
| Filed | Company |
|---|---|
| Feb 6 | RenovoRx, Inc. (RNXT) public offering
[SEC] |
| Feb 6 | Eikon Therapeutics (EIKN) public offering
[SEC] |
| Feb 6 | Cingulate Inc. (CING) $6.5M
private placement
[SEC] |
| Feb 5 | LB PHARMACEUTICALS INC (LBRX) $100.0M
private placement
[SEC] |
| Feb 5 | MBX Biosciences (MBX) $87.1M
atm
[SEC] |
| 6 more on the RxDataLab platform | |
About This Data
These events are extracted from SEC 8-K filings using keyword detection across the full filing text. Summaries are generated automatically from the filing content to describe what happened in plain language. We track five categories:
- FDA Actions (CRL): Companies that received a Complete Response Letter from the FDA, the agency's formal notice that a drug application cannot be approved as submitted.
- PDUFA Dates: Upcoming FDA decision deadlines disclosed via 8-K. A PDUFA date is the statutory deadline by which the FDA must complete its review of a new drug application.
- Strategic Reviews: Companies disclosing that they are exploring "strategic alternatives," potential sales, or board-level reviews of company direction.
- Licensing Deals: Material definitive agreements involving licensing, collaboration, or partnership arrangements. Requires multiple keyword matches to reduce noise.
- Financing Events: Capital raises, ATM offerings, registered direct transactions, and debt issuances. Filing proceeds are extracted where disclosed.
On the RxDataLab platform, each event is cross-referenced with the company's clinical trial pipeline, insider trading activity, and financials.
Data from RxDataLab and SEC EDGAR.